It is widespread even among medical professionals as well as medical historians that the formal term of the general anesthetic that Hanaoka developed is Tsusensan and its alias name is Mafutsusan. Hanaoka himself, however, described it as Mafutsusan in his Nyugan Chikenroku, the case report of the first breast cancer excision under general anesthesia with the anesthetic, and a large number of his disciples all used the term Mafutsusan to denote the anesthetic in their manuscripts. The description of Tsusensan has not been found in the documents written in the Edo period, and this name is detected only in the epitaph of Hanaoka. Consequently, we should refer to Hanaoka's anesththetic as "Mafutsusan, another name Tsusensan" instead of "Tsusensan, another name Mafutsusan."
Download full-text PDF |
Source |
---|
Anesth Analg
August 2024
Department of Anesthesiology and Critical Care Medicine, Asahikawa Medical University, Asahikawa, Japan.
Orv Hetil
August 2024
1 University of West Bohemia, Faculty of Arts, Department of Historical Sciences Pilsen Sedlackova 38, 301 00 Pilsen Czech Republic.
Circ J
May 2024
Department of Cardiovascular Medicine, Teikyo University Hospital.
Background: The 1-year clinical outcomes of the Absorb GT1 Japan post-market surveillance (PMS) suggested that an appropriate intracoronary imaging-guided bioresorbable vascular scaffold (BVS) implantation technique may reduce the risk of target lesion failure (TLF) and scaffold thrombosis (ST) associated with the Absorb GT1 BVS. The long-term outcomes through 5 years are now available.
Methods and results: This study enrolled 135 consecutive patients (n=139 lesions) with ischemic heart disease in whom percutaneous coronary intervention (PCI) with the Absorb GT1 BVS was attempted.
Am J Cardiol
January 2024
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Am J Cardiol
October 2023
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!